Nav: Home

Mexico's sugar-sweetened beverage tax may reduce diabetes, CVD, and costs over 10 years

November 01, 2016

The national 10% tax on sugar-sweetened beverages (SSBs) in Mexico is projected to have a substantial impact on the burden of diabetes, cardiovascular diseases, and mortality over the next 10 years, according to a modeling study published in PLOS Medicine. The study, conducted by Kirsten Bibbins-Domingo of the University of California San Francisco, and colleagues, indicates that 983 million international dollars in healthcare costs may be saved from the prevention of diabetes cases alone.

The prevalence of obesity and diabetes in Mexico has risen dramatically in recent years, and the rate of diabetes in Mexico currently ranks among the highest in the world. In order to address the obesity and diabetes epidemic, the Mexican government implemented a 10% excise tax on SSBs in 2014. In this study, the researchers developed a Mexico version of an established model of cardiovascular disease in the US (the Cardiovascular Disease Policy Model) and used survey data on household consumption in Mexico since the tax implementation to project health and healthcare cost impact in the next 10 years. The researchers found that the 10% tax on SSBs will likely prevent approximately 189,300 (95% uncertainty interval [UI] 155,400-218,100) new cases of type 2 diabetes, 20,400 (95% UI 17,200-24,000) incident strokes and heart attacks, and 18,900 (95% UI 15,500-22,700) deaths over 10 years among adults 35-94 years of age, and is expected to result in 983 million international dollars (95% UI $769 million-$1,173 million) in savings in healthcare costs due to prevention of diabetes cases.

The conclusions are limited by the assumptions in the model, and some epidemiologic parameters were drawn from populations outside Mexico. However, the findings suggest that, if consumption trends continue, the tax may confer significant benefits to people living in Mexico. The authors state, "[t]he SSB tax may be an important component in a multifaceted strategy by the Mexican government to curb the obesity and diabetes epidemic in Mexico."
-end-
Funding:

Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under Award Number R03TW009061 (AF, KBD, SB) and by a Grant for Collaborative Projects from the University of California Institute for Mexico and the United States (UC MEXUS) and the National Council of Science and Technology (CONACYT) Mexico (KBD, SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

Sánchez-Romero LM, Penko J, Coxson PG, Fernández A, Mason A, Moran AE, et al. (2016) Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study. PLoS Med 13(11): e1002158. doi:10.1371/journal.pmed.1002158

Author Affiliations:

Center for Nutrition and Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico
Department of Epidemiology and Public Health, University College London, London, United Kingdom
Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America
UCSF Center for Vulnerable Populations at San Francisco General Hospital, San Francisco, California, United States of America
Division of General Internal Medicine, Columbia University Medical Center, New York, New York, United States of America
Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico
Department of Epidemiology, Oregon State University, Corvallis, Oregon, United States of America
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of AmericaIN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://journals.plos.org/plosmedicine/article?id=10.1371/j

PLOS

Related Diabetes Articles:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.
Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.
Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).
Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.
Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.